fda compounding semaglutide enforcement november 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our March 31, 2025: Senator asks

Many patients reduce their dose or quit entirely because of GI discomfort

Published online July 22, 2024

India as an emerging clinical trial hub India is rapidly establishing itself as a key clinical trial hub, with trial share growth (the relative increase in number of trials sponsored by Indian headquartered companies compared to other key markets) up 109% since 2019, albeit from a low base

Natural GLP-1 Support: Fiber, SCFAs, Akkermansia & Prebiotics What youll learn: Evidence-based strategies to support natural GLP-1 physiology through fiber, resistant starch, polyphenols, and beneficial microbes like Akkermansia

You might also feel numbness or tingling in the hands and feet , have trouble walking, or notice changes in thinking

However, clinical trials describe population averages rather than individual responses